课题基金 / 基金详情

Designing a component in prophylactic vaccine to induce broad cross-genotype neutralization against heterogeneous clades of HCV

Designing a component in prophylactic vaccine to induce broad cross-genotype neutralization against heterogeneous clades of HCV
设计预防性疫苗中的一种成分,以诱导针对 HCV 异质分支的广泛跨基因型中和
批准号:
409664
负责人:
Houghton Michael
金额:
$55.45万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-09-01 至 2024-09-01

项目摘要

项目成果

Houghton Michael的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Hepatitis C virus (HCV) causes chronic liver infection with life-threatening complications. Effective antivirals have recently become available but their use is limited because of high costs and cured patients can still be reinfected. Therefore, a prophyl
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COVID-19 Variant Supplement - Production of a recombinant S ( spike ) protein vaccine against SARS-CoV-2 and emerging coronaviruses
  • 批准号:
    443190
  • 项目类别:
    Operating Grants
  • 资助金额:
    $3.64万
  • 财政年份:
    2021
  • 负责人:
    Houghton Michael
  • 依托单位:
COVID-19 Variant Network - Production of a recombinant S ( spike ) protein vaccine against SARS-CoV-2 and emerging coronaviruses
  • 批准号:
    443332
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2021
  • 负责人:
    Houghton Michael
  • 依托单位:
Production of a recombinant S ( spike ) protein vaccine against SARS-CoV-2 and emerging coronaviruses
  • 批准号:
    422769
  • 项目类别:
    Operating Grants
  • 资助金额:
    $43.71万
  • 财政年份:
    2020
  • 负责人:
    Houghton Michael
  • 依托单位:
Develop low-cost prophylactic vaccines against HCV, and therapeutic vaccines against HBV
  • 批准号:
    229025
  • 项目类别:
  • 资助金额:
    $728.5万
  • 财政年份:
    2010
  • 负责人:
    Houghton Michael
  • 依托单位:
国内基金
海外基金
新生期接种乙肝疫苗(hepatitis B vaccine,HBV)影响小鼠情绪相关行为及其机制研究
  • 批准号:
    31600836
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2016
  • 负责人:
    杨俊华
  • 依托单位: